Skip to main content
. Author manuscript; available in PMC: 2023 Oct 6.
Published in final edited form as: Qual Health Res. 2020 Jun 18;30(13):2019–2032. doi: 10.1177/1049732320929649

Table 1.

Characteristics of 17 Young Women With a Breast Cancer History at Time of Interview.

Demographic Characteristics N or M (SD)
Education
 Some or graduated college (13–16 years) 10
 Professional/graduate degree (≥17 years) 7
Marital status
 Married/engaged 13
 Divorced 3
 Single/never married 1
Parity
 Nulliparous (0 births) 2
 Primiparous (1 birth) 4
 Multiparous (≥2 births) 11
Birth of child(ren) relative to breast cancer diagnosis date
 No births 2
 Birth(s) occurred before diagnosis 12
 Birth(s) occurred after diagnosis 1
 Birth(s) occurred before and after diagnosis 2
Race/ethnicity
 White, non-Hispanic 10
 Black, non-Hispanic 5
 Other 2
Smoking
 Never smoked 14
 Former smoker 3
Stagea
 Stage 0 (in situ) 2
 Stage 1 4
 Stage 2 7
 Stage 3 3
 Unsure 1
Hormone receptor statusa
 ER+/PR+ 9
 ER+/PR− 4
 ER−/PR− 1
 ER−/PR−/HER2− (triple negative) 3
Treatment typea,b
 Lumpectomy 12
 Unilateral mastectomy 3
 Bilateral mastectomy 4
 Chemotherapy 11
 Radiation 12
 Breast reconstruction 5
 Adjuvant endocrine therapy 14
Breast cancer recurrence
 1 breast cancer diagnosis 15
 2 or more breast cancer diagnoses 2
BRCA mutation
 No 12
 Yes 1
 Variants of unknown significance 1
 Not tested 3
Time since diagnosisa
 <1 year 2
 1 ≤ years < 5 6
 5 ≤ years < 10 4
 ≥ 10 years 5
Age at diagnosis (in years)a 38.6 (5.0)
 Range 28–45
Age at time of interview (in years) 45.8 (7.2)
 Range 37–64

Note. ER = estrogen receptor; PR = progesterone receptor;

HER2 = human epidermal growth factor receptor 2

a

Refers to participant’s first breast cancer diagnosis.

b

This column does not add up to 100% since a participant may be included in >1 category based on their treatment regimen.